A Randomized Phase II Trial of 5-Day Versus 10-Day Schedules of Decitabine for Older Patients with Previously Untreated Acute Myeloid Leukemia

被引：0
|
作者：
Short, Nicholas J.
Kantarjian, Hagop M.
Garcia-Manero, Guillermo
Borthakur, Gautam
Kadia, Tapan
Huang, Xuelin
Daver, Naval
DiNardo, Courtney D.
Ferrajoli, Alessandra
Wierda, William G.
Estrov, Zeev
Benton, Christopher B.
Bose, Prithviraj
Alvarado, Yesid
Kornblau, Steven
Ohanian, Maro
Gaisor, Yvonne
Richie, Mary Ann
Pierce, Sherry
Jabbour, Elias J.
Cortes, Jorge E.
Ravandi, Farhad
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2577
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial
    Short, Nicholas J.
    Kantarjian, Hagop M.
    Loghavi, Sanam
    Huang, Xuelin
    Qiao, Wei
    Borthakur, Gautam
    Kadia, Tapan M.
    Daver, Naval
    Ohanian, Maro
    Dinardo, Courtney D.
    Estrov, Zeev
    Kanagal-Shamanna, Rashmi
    Maiti, Abhishek
    Benton, Christopher B.
    Bose, Prithviraj
    Alvarado, Yesid
    Jabbour, Elias
    Kornblau, Steven M.
    Pemmaraju, Naveen
    Jain, Nitin
    Gasior, Yvonne
    Richie, Mary Ann
    Pierce, Sherry
    Cortes, Jorge
    Konopleva, Marina
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    LANCET HAEMATOLOGY, 2019, 6 (01): : E29 - E37
  • [2] Efficacy of 10-day decitabine in acute myeloid leukemia
    Bouligny, Ian M.
    Mehta, Vivek
    Isom, Scott
    Ellis, Leslie R.
    Bhave, Rupali R.
    Howard, Dianna S.
    Lyerly, Susan
    Manuel, Megan
    Dralle, Sarah
    Powell, Bayard L.
    Pardee, Timothy S.
    LEUKEMIA RESEARCH, 2021, 103
  • [3] Five-Day Versus Ten-Day Schedules of Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase II Study
    Short, Nicholas J.
    Kantarjian, Hagop M.
    Loghavi, Sanam
    Huang, Xuelin
    Qiao, Wei
    Borthakur, Gautam
    Kadia, Tapan M.
    Daver, Naval G.
    Ohanian, Maro N.
    DiNardo, Courtney D.
    Estrov, Zeev E.
    Kanagal-Shamanna, Rashmi
    Maiti, Abhishek
    Benton, Christopher B.
    Bose, Prithviraj
    Alvarado, Yesid
    Jabbour, Elias J.
    Kornblau, Steven M.
    Pemmaraju, Naveen
    Jain, Nitin
    Gasior, Yvonne
    Richie, Mary Ann
    Pierce, Sherry A.
    Cortes, Jorge E.
    Konopleva, Marina Y.
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    BLOOD, 2018, 132
  • [4] Phase II Trial of 10-Day ASTX727 (Decitabine/Cedazuridine) with Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia
    Maiti, Abhishek
    DiNardo, Courtney D.
    Ohanian, Maro
    Daver, Naval
    Borthakur, Gautam
    Chien, Kelly S.
    Issa, Ghayas C.
    Takahashi, Koichi
    Masarova, Lucia
    Valero, Yesid Alvarado
    Jabbour, Elias
    Wierda, William G.
    Short, Nicholas J.
    MacFarland, Melissa
    Pike, Allison
    Kadia, Tapan M.
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Konopleva, Marina Y.
    BLOOD, 2023, 142
  • [5] Preliminary Results of a Multicenter Phase II Trial of 5-Day Decitabine as Front-Line Therapy for Elderly Patients with Acute Myeloid Leukemia (AML)
    Cashen, Amanda F.
    Schiller, Gary J.
    O'Donnell, Margaret R.
    Larsen, Julie S.
    Baranwal, Akhil
    Cullen, Michael T.
    DiPersio, John F.
    BLOOD, 2008, 112 (11) : 210 - 210
  • [6] EFFICACY OF DECITABINE IN 10-DAY REGIMEN IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA INELIGIBLE FOR INTENSIVE CHEMOTHERAPY
    Moreno de Gusmao, B.
    Esteves, I.
    Santos, F. P. S.
    Petrolli, M.
    Ferreira, F.
    Galvao, C., Jr.
    Perini, G.
    Hyppolito, J.
    Helman, R.
    Hamersclak, N.
    LEUKEMIA RESEARCH, 2015, 39 : S113 - S113
  • [7] EFFICACY OF DECITABINE IN 10-DAY REGIMEN IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA INELIGIBLE FOR INTENSIVE CHEMOTHERAPY
    Moreno De Gusmao, B.
    Esteves, I.
    Petrolli, M.
    Hyppolito, J.
    Santos, F.
    Ferreira, F.
    Perini, G.
    Helman, R.
    Hamerschlak, N.
    HAEMATOLOGICA, 2015, 100 : 653 - 653
  • [8] Interim Analysis of Phase II Study of Venetoclax with 10-Day Decitabine (DEC10-VEN) in Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Maiti, Abhishek
    DiNardo, Courtney D.
    Cortes, Jorge E.
    Borthakur, Gautam
    Pemmaraju, Naveen
    Benton, Christopher B.
    Kadia, Tapan M.
    Takahashi, Koichi
    Naqvi, Kiran
    Ravandi, Farhad
    Alvarado, Yesid
    Short, Nicholas J.
    Daver, Naval G.
    Sasaki, Koji
    Ohanian, Maro N.
    Garcia-Manero, Guillermo
    Thompson, Philip A.
    Kornblau, Steven M.
    Masarova, Lucia
    Jain, Nitin
    Jabbour, Elias J.
    Andreeff, Michael
    Maduike, Rita
    Guerrero, Julio A.
    Zhang, Qi
    Cavazos, Antonio
    Ma, Helen
    Rausch, Caitlin R.
    Bivins, Carol A.
    Vaughan, Kenneth
    Pierce, Sherry A.
    Ning, Jing
    Qiao, Wei
    Welch, John S.
    Kantarjian, Hagop M.
    Konopleva, Marina Y.
    BLOOD, 2018, 132
  • [9] Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen
    Ali, Alaa M.
    Weisel, Daniel
    Gao, Feng
    Uy, Geoffrey L.
    Cashen, Amanda F.
    Jacoby, Meagan A.
    Wartman, Lukas D.
    Ghobadi, Armin
    Pusic, Iskra
    Romee, Rizwan
    Fehniger, Todd A.
    Stockerl-Goldstein, Keith E.
    Vij, Ravi
    Oh, Stephen T.
    Abboud, Camille N.
    Schroeder, Mark A.
    Westervelt, Peter
    DiPersio, John F.
    Welch, John S.
    CANCER MEDICINE, 2017, 6 (12): : 2814 - 2821
  • [10] A RANDOMIZED CONTROLLED TRIAL OF 5-DAY REGIMENT OF AZITHROMYCIN AND A 10-DAY REGIMENT OF CO-AMOXICLAV FOR TREATMENT OF ACUTE SINUSITIS
    Lari, A. Rastegar
    Alaghehbandan, R.
    PEDIATRIC RESEARCH, 2011, 70 : 480 - 480
12345